Expert Review of Respiratory Medicine

• EASD 2022
  September 22, 2022
• ESMO 2022
  September 09, 2022
• ESC 2022
  August 26, 2022
• ECO 2022
  May 05, 2022
• ECCMID 2022
  April 21, 2022
• ACC 2022
  April 20, 2022
• BSH 2022
  April 20, 2022
• DUKPC 2022
  April 01, 2022
• SfE BES 2021
  November 12, 2021
• NCRI 2021
  November 12, 2021
• DPC 2021
  November 12, 2021
• AHA 2021
  November 10, 2021
• RCP Med+ 2021
  October 26, 2021
• RCGP 2021
  October 14, 2021
• EASD 2021
  September 30, 2021
• ESMO 2021
  September 30, 2021
• ESOC 2021
  September 30, 2021
• BCS 2021
  September 30, 2021
• ERS 2021
  September 28, 2021
• ARM 2021
  September 20, 2021
• Personalizing and Targeting Therapy for COPD Find out how potential clinical biomarkers for COPD could be used to personalize treatment and lead to improved disease management.
  Expert Review of Respiratory Medicine, February 10, 2014
• Advances in Airway Clearance Technologies for COPD Get evidence based clinical recommendations about airway clearance techniques -- for patients with chronic obstructive pulmonary disease.
  Expert Review of Respiratory Medicine, January 10, 2014
• Advances in Pneumococcal Antibiotic Resistance Will widespread use of pneumococcal conjugate vaccines be enough to reduce the growing threat of drug-resistant 19A pneumococci?
  Expert Review of Respiratory Medicine, December 11, 2013
• Potential Role of Statins in COPD and Its Co-morbidities Get the latest evidence on why statins have a beneficial effect in patients with COPD.
  Expert Review of Respiratory Medicine, November 11, 2013
• Climate Change and Respiratory Health Climate change is a key driver of the accelerating environmental change affecting populations around the world. Many of these changes and our response to them can affect respiratory health.
  Expert Review of Respiratory Medicine, October 11, 2013
• COPD Updates: What's New in Pathophysiology and Management? Learn more about current thinking regarding COPD and find out how three different mechanisms of airflow obstruction play a role in COPD pathogenesis.
  Expert Review of Respiratory Medicine, September 12, 2013
• Ambulatory Strategies for Obstructive Sleep Apnea in Adults Is ambulatory monitoring an efficacious way to treat obstructive sleep apnea?
  Expert Review of Respiratory Medicine, August 05, 2013
• The Misuse of Asthma Drugs Learn about the three biggest problems with asthma care in the USA today and how misuse of asthma drugs contributes to each.
  Expert Review of Respiratory Medicine, July 03, 2013
• Post-Breast Cancer Radiotherapy BOOP Get the scoop on BOOP in breast cancer survivors.
  Expert Review of Respiratory Medicine, June 04, 2013
• The Association Between Acetaminophen and Asthma Is acetaminophen a real asthma promoter or an innocent bystander?
  Expert Review of Respiratory Medicine, May 03, 2013
• New Therapeutic Targets in Pulmonary Arterial Hypertension Current therapeutic strategies are mainly designed to induce relaxation of the pulmonary arteries, not to improve vascular remodeling that characterizes PAH. Will newer agents remodel the vasculature?
  Expert Review of Respiratory Medicine, April 04, 2013
• Role of Inflammatory Biomarkers to Predict Mortality in COPD Which serum inflammatory biomarkers are associated with an increased risk of death?
  Expert Review of Respiratory Medicine, March 03, 2013
• Effects of Vitamin D on Immune Disorders Learn more about the role of vitamin D in immunological disorders and how it inhibits immune reactions in general . . .
  Expert Review of Respiratory Medicine, February 18, 2013
• Acute Asthma Exacerbations in Childhood Childhood asthma may remain dormant for extended periods, but the inflammatory and remodeling processes can lead to acute and occasionally severe clinical manifestations.
  Expert Review of Respiratory Medicine, February 03, 2013
• Morbidities Associated With Obstructive Sleep Apnea Learn more about why obstructive sleep apnea can cause metabolic dysregulation, oxidative stress, neurohumoral changes and many more comorbid circumstances.
  Expert Review of Respiratory Medicine, January 03, 2013
• Management of VAP Caused by Multidrug-Resistant Pathogens The incidence of VAP due to multi-drug resistant pathogens has increased significantly in the last decade. What are we doing to manage it?
  Expert Review of Respiratory Medicine, November 01, 2012
• Targeting Interleukins to Treat Severe Asthma Inflammatory changes in asthma are driven by immune mechanisms, within which interleukins play an integral role. Find out more about the potential clinical benefits.
  Expert Review of Respiratory Medicine, October 31, 2012
• COPD Assessment Test in the Evaluation of COPD Exacerbations Learn more about an evaluation tool for COPD that may have multiple clinical applications.
  Expert Review of Respiratory Medicine, August 01, 2012
• Efficacy of Anticholinergic Drugs in Asthma Should anticholinergic drugs play more of a leading role in chronic asthma management?
  Expert Review of Respiratory Medicine, August 30, 2012
• Inhaled Treprostinil for Pulmonary Arterial Hypertension For pulmonary arterial hypertension treatment, learn more about the pharmacodynamics, pharmacokinetics, clinical efficacy and safety of inhaled treprostinil.
  Expert Review of Respiratory Medicine, June 01, 2012